AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

L-Lysine

10 registrations across 2 African markets— 9 active

Markets with L-Lysine

Recent registrations

Brand / ProductMarketHolderStatusExpires
PROAMINO-L POWDER (EACH L-lysine 98.5%w/w)🇬🇭GhanaactiveMay 2028
PROAMINO-L POWDER (EACH L-lysine 98.5%w/w)🇬🇭GhanaactiveMay 2028
PROAMINO-L POWDER🇬🇭GhanaactiveOct 2026
PROAMINO-L POWDER🇬🇭GhanaexpiredOct 2026
PROAMINO-L POWDER🇬🇭GhanaactiveOct 2026
L-Lysine
Capsule
🇰🇪KenyaArmaan Ltdactive
Holland & Barrett L-Lysine 1000mg
Coated Tablet
🇰🇪KenyaHolland & Barrettactive
MVC - L-Lysine 500mg
Capsule
🇰🇪KenyaPremier Health Products Ltdactive
Holland & Barrett L-Lysine 500mg
Coated Tablet
🇰🇪KenyaHolland & Barrettactive
L-Lysine
Capsule
🇰🇪KenyaGM MEDICAL & SUPPLIES LTDactive

L-Lysine in Africa — Regulatory Overview

L-Lysine is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Kenya. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 9 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.